© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness
In this 27-minute video, I explain the risks associated with exosomes.
Reading Time: < 1 minute
The Risks of Exosomes – Lecture 8 of 9
In this 27-minute video, I explain the risks associated with exosomes. These include infection, potency, consistency, wasted funds, and unknown unknowns. Exosomes are not inert; they make powerful changes. But the most important thing to understand is not the placebo effect, nocebo effect, or how much you spend. The most important thing to understand is what your own risk tolerance is and if you really want to change.
The series covers the following topics:
Lecture 1: What are exosomes?
Lecture 2: Aging and exosomes
Lecture 3: Parabiosis and exosomes
Lecture 4: Cancer and exosomes
Lecture 5: A history of regenerative therapies in joints
Lecture 6: Are all exosomes created equal?
Lecture 7: The FDA
Lecture 8: What are the risks of exosomes?
Lecture 9: What is Dr. Park’s approach to exosomes?
If you are interested in learning more about the real life clinical anecdotes from exosome users, please email me directly at drpark@rechargebiomedical.com
I like to know each person who is receiving those private emails because I do not want those private blogs to be misconstrued as medical claims nor as advertising. I need your name, date of birth, a phone number, and a brief summary of why you are interested.
As a subscriber, you will have access to my password-protected blogs but you will need to add the above email to your email contacts to make sure they don’t go to spam.
